The evolution of Hospital-at-Home (HaH) and Direct Home Medical implementation services in Singapore has reshaped acute care delivery by decentralising inpatient services into residential environments.
Building on this model, the Hospital-at-Nursing Home (HaNH) pilot introduced by the Ministry of Health extended hospital-level care directly into nursing homes.
Preliminary findings from Sengkang General Hospital demonstrate feasibility, comparable length of stay to traditional HaH, and meaningful benefits in admission avoidance and early supported discharge.
However, nursing home residents represent a more vulnerable cohort with higher frailty, multimorbidity, and post-discharge risks. These findings underscore a crucial insight: while clinical models are foundational, the success of implementation relies heavily on robust remote diagnostics, real-time monitoring infrastructure, and trusted technology partners.
For nursing homes in Singapore, partnering with a white-labelled, trusted direct home medical device provider can bridge operational gaps, strengthen clinical oversight, and increase the success rate of Hospital-at-Home extensions.
Introduction: A Growing Need for Alternative Acute Care
Singapore’s rapidly ageing population has intensified healthcare demand. In 2023 alone, older adults (≥65 years) accounted for:
- 56.3% of hospital admissions
- 66.8% of total hospital bed days
- An average hospital stay of 8 days for nursing home residents (vs. 5-day national average)
Traditional hospitalisation often leads to:
- Functional decline
- Delirium
- Hospital-acquired infections
- Increased system strain
The Hospital-at-Home (HaH) programme, introduced in Singapore in 2018 and expanded during COVID-19, demonstrated that inpatient-level care can be delivered safely in patients’ homes through remote monitoring, medication administration, and virtual consultations.
Recognising its benefits, the Ministry of Health approved the pioneering HaNH pilot, which brings hospital-level services directly into nursing homes.
The HaNH Pilot: Study Design and Clinical Outcomes
Between November 2023 and December 2024, a prospective study compared:
- HaNH cohort: 16 nursing home residents
- HaH cohort: 349 community-dwelling patients
Patient Profile
HaNH patients were significantly older (mean age 80.3 years vs. 54.5 years in HaH).
Common diagnoses included:
- Pneumonia (56.3%)
- Urinary tract infections / Pyelonephritis (18.8%)
Length of Stay
The median length of stay in HaNH was 3 days, statistically comparable to HaH (p = 0.73).
This demonstrates that hospital-level treatment can be delivered efficiently within nursing homes without prolonging illness duration.
Escalation to Hospital
Escalation to physical hospital facilities occurred in:
- 18.8% of HaNH patients
- 3.4% of HaH patients
Although adjusted risk (aRR = 1.32) attenuated after accounting for age and gender, the findings highlight a central issue:
Nursing home residents are clinically fragile and require tighter monitoring thresholds.
Post-Discharge Vulnerability: The Critical Window
HaNH patients demonstrated higher post-discharge risks, particularly within 30 days:
- Mortality (RR = 10.9)
- Emergency Department visits (RR = 3.18)
Risks declined over 60 and 90 days but remained elevated compared to HaH.
This trend aligns with global literature: nursing home residents have lower physiological reserves and higher frailty burdens.
Yet, an important nuance emerges:
The higher risk profile does not invalidate HaNH. Rather, it underscores the necessity of a stronger diagnostic infrastructure within nursing homes.
Why HaNH Still Represents a Major Advancement
Despite higher escalation and post-discharge events, HaNH offers substantial system-level and patient-centred benefits:
1. Reduced Hospital Bed Utilisation
In land-scarce Singapore, building more infrastructure is unsustainable. HaNH alleviates bed shortages.
2. Admission Avoidance & Early Supported Discharge
Three patients avoided hospital admission entirely. Thirteen were discharged early from the wards.
3. Reduced Hospital-Acquired Infections
Nursing home residents remain in familiar environments, lowering exposure to nosocomial pathogens.
4. Goal-Concordant End-of-Life Care
One mortality occurred under palliative care, aligned with the patient’s preferred place of death, an ethically significant outcome.
The Missing Link: Technology Readiness in Nursing Homes
The study identified operational challenges:
- Resource constraints
- Increased workload on nursing staff
- Need for close monitoring of pneumonia and UTI
- Escalation due to delayed deterioration detection
These findings point to a systemic requirement:
Hospital-level care cannot rely on clinical workflows alone; it demands reliable, integrated medical technology.
Without real-time monitoring and standardised diagnostic tools, escalation risk remains high.
The Role of Direct Home Medical Devices
To strengthen Hospital at Home implementation, nursing homes require:
- Continuous vital sign monitoring
- Secure teleconsultation interfaces
- Cloud-based data dashboards
- Structured escalation alerts
- Standardised diagnostic kits
A white-labelled Direct Home Medical and Remote Patient Monitoring (RPM) solution enables nursing homes to operate with hospital-grade infrastructure while maintaining branding continuity and operational autonomy.
Why White-Labelled Partnerships Increase Success Rates
1. Standardisation of Care
A trusted provider ensures calibrated, hospital-grade devices (BP monitors, pulse oximeters, digital thermometers, ECG patches) that align with acute care protocols.
2. Real-Time Escalation
Automated alerts reduce the delay in detecting:
- Desaturation in pneumonia
- Tachyarrhythmias
- Sepsis markers
This directly addresses the primary escalation drivers identified in HaNH.
3. Staff Empowerment
With intuitive dashboards and training support:
- Nursing staff gain confidence
- Physician time is optimised
- Communication gaps narrow
4. Data-Driven Predictive Modeling
Structured RPM data enables predictive analytics for:
- Early deterioration signals
- Risk stratification
- Tailored patient selection
This directly supports the study’s recommendation for improved inclusion criteria and predictive modelling.
Case Reflection: What the HaNH Pilot Teaches Us
The HaNH pilot demonstrates three key lessons:
- Feasibility is proven.
- Frailty risk is real but manageable.
- Infrastructure maturity determines scalability.
While the pilot achieved a comparable length of stay to HaH, escalation and post-discharge events highlight an implementation gap, not a model failure.
Strengthening technology ecosystems can meaningfully reduce these risks.
Scaling Hospital-at-Home in Singapore: The Strategic Opportunity
Singapore’s Ministry of Health is actively exploring the expansion of value-based care models nationwide.
For broader rollout, the system must address:
- Cost-effectiveness
- Workforce capacity
- Diagnostic readiness
- Caregiver confidence
White-labelled Direct Home Medical providers offer scalability advantages:
- Rapid deployment kits
- Device lifecycle management
- Training modules
- Integrated telehealth platforms
- Customisable branding for institutional partners
Such partnerships reduce operational friction and improve stakeholder confidence, particularly among family members who may initially perceive brick-and-mortar hospitals as superior.
Bridging Comfort and Professional Diagnostics
The essence of Hospital at Home lies in reconciling two traditionally opposing paradigms:
| Traditional Hospital | Nursing Home Setting |
| High diagnostic capacity | High comfort & familiarity |
| Risk of delirium | Reduced stress |
| High infection exposure | Controlled environment |
| Centralised resources | Limited infrastructure |
Direct home medical technology bridges this divide.
With hospital-grade remote diagnostics embedded in nursing homes, residents receive:
- Comfort of familiarity
- Professional oversight
- Reduced hospital transfers
- Better alignment with personal care preferences
Conclusion
The Hospital-at-Nursing Home pilot marks a transformative milestone in Singapore’s healthcare evolution.
While nursing home residents inherently carry a higher clinical risk, the previous cases and programmes demonstrated feasibility, comparable length of stay, and meaningful admission avoidance.
The higher escalation and post-discharge risks do not diminish the model’s value. Rather, they illuminate the necessity for:
- Stronger monitoring infrastructure
- Standardised diagnostic tools
- Integrated remote patient monitoring
- Trusted technology partnerships
In the next phase of Hospital-at-Home expansion, success will not depend solely on clinical protocols, but on the ecosystem that supports them.
By partnering with a white-labelled and trusted Direct Home Medical provider, nursing homes can confidently bridge the gap between comfort and professional diagnostics, ensuring that acute care remains not only accessible but safe, scalable, and future-ready in Singapore.
The Smart Future Approach
As a white-labelled Direct Home Medical and Remote Patient Monitoring provider in Singapore, Smart Future aligns with the future trajectory of Hospital-at-Home expansion.
Our approach supports:
- Hospital-grade device deployment
- Secure remote dashboards
- Early warning systems
- Workflow integration
- Customisable institutional branding
By enabling nursing homes to deliver acute-level monitoring seamlessly, Smart Future helps reduce escalation risk and support sustainable scalability.










